DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20221169

Peptic ulcer disease in school children aged 2-11 years in Southeast Nigeria

Emmanuel I. Umegbolu

Abstract


Background: A peptic ulcer is a sore on the inner lining of the stomach or duodenum, caused mainly by non-steroidal anti-inflammatory drugs and Helicobacter pylori infection. In childhood, peptic ulcer disease (PUD) is an uncommon disease, with an estimated frequency of 1 case in 2, 500 hospital admissions in the United States. Data for developing countries, including Nigeria, are scarce, although peptic ulceration is being increasingly recognized in children in the developing world now. For this reason, this study was designed to investigate PUD in school children in Southeast Nigeria.

Methods: 264 children, aged 2-11 years, who attended Cottage Hospital Inyi in 2020 with complaints of abdominal pain were investigated for PUD with stool antigen test. Data collected for a period of one year were analysed as proportions and Chi square, using MaxStat (version 3.60) statistical software. P≤0.05 was considered significant.

Results: The prevalence of PUD was 16%; 8.3% in females and 7.6% in males. In the 2-6 years age group prevalence was 7%, while in the 7-11 years age group it was 9%. Association between sex and prevalence of PUD was not significant (p=0.62), but very significant for that with age (p=0.0003).

Conclusions: Prevalence of PUD was 16%. This increased with age (7% in the 2-6 years age group and 9% in the 7-11 years group). To address the rising prevalence of PUD in these children, there is need to monitor their feeding habits in school, besides teaching them the importance of personal hygiene.  


Keywords


Peptic, ulcer, Disease, H. pylori, Childhood, Nigeria

Full Text:

PDF

References


National Institute of Diabetes and Digestive and Kidney Diseases. Peptic Ulcer Disease and H. pylori, 2014. Available at: www.digestive.niddk. nih.gov. Accessed on 20 November 2021.

Al-Enezi M, Al Shehry A. Pathology and pathophysiology of peptic ulcer disease, 2012. Available at: https://www.hopkinsmedicine.org. Accessed on 20 November 2021.

Dunlap JJ, Patterson S. Focus on clinical assessment: peptic ulcer disease. Soc Gastroenterol Nurs. 2019;42(5):451-4.

Saif SR, Haider M, Niyaz Z, Siddique F, Abrar DR. Drugs for peptic ulcer. In: Pharmacology Review. 1sted. New Delhi: CBS. 2005;483-95.

Lanas A, Chan FKI. Peptic ulcer disease. The Lancet. 2017;390:613-24.

Chong SKF, Lou Q, Zollinger TW, Tolia V, Elitsur Y, Gold BD, et al. The sero-prevalence of Helicobacter pylori in a referral population of children in the United States. Am J Gastroenterol. 2003;98:2162-8.

Ozen A, Ertem D, Pchlivanoglu E. Natural history and symptoms of Helicobacter pylori in childhood and factors determining the epidemiology of infection. J Paed Gastroenterol Nutr. 2006;42:398-404.

Sullivan PB. Peptic ulcer disease in children. Paediatrics and Child Health. 2010;20(10):462-4.

Charpignon C, Lesgourgues B, Pariente A, Nahon S, Pelaquier A, Gatineau-Sailliant G, et al. Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake. Al Pharmacol Ther. 2013;38:946-54.

Levenstein S, Rosenstock S, Jacobsen RK, Jorgensen T. Psychological stress increases risk of ulcer, regardless of Helicobacter pylori infection or use of nonsteroidal anti-inflammatory drug. Clin Gastroenterol Hepatol. 2015;13:498-506.el.

Chung CS, Ching TH, Lee YC. A systematic approach for the diagnosis and treatment of idiopathic ulcers. Kor J Intern Med. 2015;30:559-70.

Søreide K, Thorsen K, Harrison EM, Bingener J, Møller MH, Ohene-Yeboah M, et al. Perforated peptic ulcer. Lancet. 2015;386:1288-98.

Freston W. Role of proton pump inhibitors in non-H. pylori- ulcers. Aliment Pharmacol Ther. 2001;15(2):2-5.

Tally NJ, Vakil N. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005;100(10):2324-37.

Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroen¬terol. 2007;102(8):1808-125.

Sverdén E, Lars Agréus L, Dunn JM, Lagergren J. Peptic ulcer disease. BMJ. 2019;367:l5495.

Kazemi S, Tavakkoli H, Habizadeh MR, Emami MH. Diagnostic values of Helicobacter pylori diagnostic tests: stool antigen test, urea breath test, rapid urease test, serology and histology. J Res Med Sci. 2011;16(9):1097-104.

Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systemic review and meta-analysis. Gastroenterol. 2017;153:420-9.

Singh N, Rattan P, Kothiyal P. Introduction to PUD- a review. J Pharm Res. 2017;11(7):878-86.

Etukudo OM, Ikpeme EE, Ekanem EE. Seroepidemiology of Helicobacter pylori infection among children seen in a tertiary hospital in Uyo, southern Nigeria. Pan Afr Med J. 2012;12:39.

Johnson-Mann C, Rawlings K, Arbizu RA, Hebra A. NSAID-induced perforated peptic ulcer in a paediatric sickle cell patient. J Paed Surg Case Rep. 2016;14:12-4.

Sowande OA, Aldrink JH. Peptic ulcer disease in children, 2011. Available at: http://www.global_ help.org. Accessed on 20 November 2021.

Akhtar F, Shelton P, Dinh A. Peptic ulcer disease In Domino F, Baldor R, Golding J, Stephens M (eds). The 5-minute Clinical Consult (27th ed). Philadelphia: Wolters Kluwer. 2019;748-9.